Neph Times Non-Sponsored
Advertisement
Kidney transplant recipients with psoriasis have a higher risk for transplant failure.
The Kidney Transplant Fast Track intervention improved patients' odds of being waitlisted, a trial found.
Kidney transplant candidates and their families often feel responsible but powerless during evaluation, a survey finds.
Use of SGLT2i with RAASi is associated with reduced risk for hyperkalemia in the clinical setting, a study found.
Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease.
AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions.
Meta-analyses reaffirmed cardiovascular and renal benefits of long-acting GLP-1RAs for patients with type 2 diabetes.
A report based on chart data and specialist surveys reveals gaps in treatment for FSGS but optimism about the drug pipeline.
The FDA has granted Orphan Drug Designation to veverimer for anti–glomerular basement membrane (anti-GBM) disease.
Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found.
Richard Furie, MD, discussed the REGENCY trial of obinutuzumab in systemic lupus erythematosus and lupus nephritis.
Treatment with a finerenone-empagliflozin combo leads to greater decreases in albuminuria in CKD and type 2 diabetes.
Pegcetacoplan reduced proteinuria and stabilized eGFR in adolescent patients with C3G or primary IC-MPGN.
An analysis confirmed the efficacy and safety of pegcetacoplan for patients with C3G/IC-MPGN and nephrotic range proteinuria.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.